ClinicalTrials.Veeva

Menu

Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care

Karolinska Institute logo

Karolinska Institute

Status

Completed

Conditions

Generalized Anxiety Disorder

Treatments

Behavioral: Intolerance of uncertainty therapy
Behavioral: Metacognitive therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT03621371
SLSO-2018/505-31/1

Details and patient eligibility

About

The feasibilty and preliminary comparative effectiveness of two methods of cognitive-behavioral therapy - metacognitive therapy and intolerance of uncertainty therapy - for primary care patients with generalized anxiety disorder is investigated in a pilot study using a randomized controlled design. Purpose of the study is to examine the feasibility of a full-scale randomized controlled trial. Research questions primarily concern recruitment, measurement, and adherence.

Enrollment

64 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary diagnosis of generalized anxiety disorder
  • Age 18 years or above
  • Being able to understand and speak Swedish without interpreter support

Exclusion criteria

  • Psychosis, bipolar disorder, severe depressive symptoms, risk of suicid, substance use disorder, intellectual disability
  • Simultaneous psychological treatment
  • If pharmacological treatment, it needs to be stable prior to and during treatment

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64 participants in 2 patient groups

Metacognitive therapy
Experimental group
Treatment:
Behavioral: Metacognitive therapy
Intolerance of uncertainty therapy
Experimental group
Treatment:
Behavioral: Intolerance of uncertainty therapy

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems